Dr.Β DepeiΒ Wu
Bachelor of Clinical Medicine, Master of Medicine (Hematology), PhD (Internal Medicine / Hematology)
Professor, Chief Physician & Doctoral Supervisor β Hematology
corporate_fareFirst Affiliated Hospital of Soochow University, Suzhou
Depei Wu
Bachelor of Clinical Medicine, Master of Medicine (Hematology), PhD (Internal Medicine / Hematology)
Prof. Depei Wu is one of China's most distinguished hematologists, serving as Professor, Chief Physician and Doctoral Supervisor at The First Affiliated Hospital of Soochow University in Suzhou. He is Director of the Department of Hematology, Executive Deputy Director of the National Clinical Research Center for Hematologic Diseases, and Director of the Institute of Blood and Marrow Transplantation at Soochow University.
With more than 40 years of clinical experience, Prof. Wu has dedicated his career to the diagnosis and treatment of leukemia, hematologic malignancies and complex blood disorders, with particular expertise in hematopoietic stem cell transplantation and post-transplant complication management. He completed overseas training at the University Hospital Center of Nantes, France (1992β1994) and as a visiting scholar at MD Anderson Cancer Center, USA (2007). His research programme spans graft-versus-host disease mechanisms, CAR-T cell therapy, precision diagnosis of blood cancers, and investigational therapies for relapsed and refractory leukemia. Prof. Wu has published hundreds of SCI-indexed papers, serves as Editor-in-Chief of the Chinese Journal of Hematology, and is a recipient of two National Science and Technology Progress Awards.
CancerFax can coordinate medical-report review and consultation support for international patients seeking care at The First Affiliated Hospital of Soochow University.
Why Consider Prof. Depei Wu?
Prof. Depei Wu combines over four decades of clinical expertise, national research leadership and a high-volume transplant programme, making him one of China's most sought-after specialists for leukemia and bone marrow transplant care.
Areas of Specialisation
Comprehensive hematology, bone marrow transplantation and cellular therapy for leukemia and blood cancers
Prof. Wu's clinical work centres on hematopoietic stem cell transplantation, leukemia management and advanced cellular therapies. His programme addresses the full spectrum of malignant and complex hematologic disorders.
Bone Marrow Transplantation & HSCT
Comprehensive allogeneic and haploidentical stem cell transplantation for leukaemia and blood cancers.
- arrow_rightTransplantation for acute myeloid and acute lymphoblastic leukaemia
- arrow_rightHaploidentical donor transplant programmes
- arrow_rightPost-transplant complication monitoring and management
- arrow_rightGVHD prevention strategies and clinical protocols
- arrow_rightMechanistic research and translational approaches to GVHD management
- arrow_rightManagement of chronic GVHD following allogeneic transplantation
Leukaemia & Haematologic Malignancies
Precision diagnosis and treatment planning for leukemia, lymphoma, myeloma and related blood disorders.
- arrow_rightAcute myeloid leukaemia (AML) β diagnosis, induction and consolidation
- arrow_rightAcute lymphoblastic leukaemia (ALL) β risk-stratified treatment planning
- arrow_rightInvestigational therapies for relapsed and refractory acute leukaemia
- arrow_rightGenomic and molecular classification of blood cancers
- arrow_rightBiomarker-driven treatment planning for multiple myeloma and lymphoma
- arrow_rightTargeted and investigational therapies guided by molecular profiling
Cellular Therapy & Immunotherapy
CAR-T cell therapy and immune-based approaches for advanced and refractory haematologic cancers.
- arrow_rightCAR-T cell therapy research and clinical application for haematologic malignancies
- arrow_rightEligibility assessment and post-CAR-T monitoring
Procedures Performed
Transplantation, systemic treatment, cellular therapy and precision haematology
Prof. Wu's clinical programme covers the full range of haematopoietic stem cell transplantation procedures, systemic treatments for blood cancers, cellular therapies and precision diagnostic approaches.
Haematopoietic Stem Cell Transplantation
TransplantAllogeneic, haploidentical and matched donor transplantation for leukaemia and blood cancers.
Systemic Treatment for Blood Cancers
Medical OncologyChemotherapy, targeted therapy and investigational agents for leukaemia, lymphoma and myeloma.
CAR-T Cell & Cellular Therapy
Targeted TherapyCellular immunotherapy approaches for eligible patients with refractory haematologic malignancies.
Precision Diagnosis & Second Opinion
Second OpinionExpert review of complex haematologic cases with molecular profiling and transplant eligibility assessment.
Research & Publications
Peer-reviewed contributions in hematology, transplantation and cellular therapy
Prof. Depei Wu has published hundreds of SCI-indexed papers and contributed to national haematology guidelines, expert consensus documents and clinical textbooks. His research covers HSCT, GVHD, leukemia biology and cellular therapy.
Prof. Wu's full publication list is available on Google Scholar (Soochow University) and through PubMed. A detailed research profile can be provided on request via CancerFax.
Education & Training
Prof. Wu completed his medical training entirely at Soochow University and Soochow Medical College, earning degrees in clinical medicine, hematology-focused internal medicine, and a doctorate in hematology. He also undertook specialist overseas training in France and the United States.
Clinical Experience
Prof. Depei Wu has spent his entire career at The First Affiliated Hospital of Soochow University, progressing from resident physician to his current role as Professor, Chief Physician and Director of the Department of Hematology. He concurrently holds senior positions at national and provincial haematology research institutions.
Languages & International
Prof. Wu consults primarily in Mandarin Chinese. CancerFax can coordinate professional medical interpreter support for international patients requiring consultations in other languages.
CancerFax can coordinate professional medical interpreter support for English-speaking and other international patients seeking consultation with Prof. Wu.
CancerFax can coordinate professional medical interpreter support for international patients as required.
How CancerFax Helps You Access Dr. Depei Wu
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Depei Wu's team β with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history β prepared as a structured clinical summary for Dr. Depei Wu's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Depei Wu before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Depei Wu's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Depei Wu's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Depei Wu's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Depei Wu
Prof. Depei Wu is a Professor, Chief Physician and Doctoral Supervisor at The First Affiliated Hospital of Soochow University in Suzhou, China. He is the Director of the Department of Hematology and Director of the Institute of Blood and Marrow Transplantation, with over 40 years of clinical experience in leukaemia and haematopoietic stem cell transplantation.
Prof. Wu specialises in leukemia (AML, ALL), bone marrow transplantation, multiple myeloma, lymphoma, myelodysplastic syndromes, graft-versus-host disease, and other complex or refractory haematologic malignancies. He has a particular focus on patients requiring haematopoietic stem cell transplantation or advanced cellular therapies such as CAR-T.
Yes. Bone marrow transplantation and haematopoietic stem cell transplantation (HSCT) are at the core of Prof. Wu's clinical and research work. He leads the Institute of Blood and Marrow Transplantation at Soochow University and directs a national haematology research centre with a high-volume transplant programme.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Wu at The First Affiliated Hospital of Soochow University, subject to hospital availability and case acceptance. Please submit your reports through CancerFax to begin the process.
Submit your medical records, pathology reports, imaging and treatment history through CancerFax. The CancerFax team will prepare the case summary and coordinate the next steps with the hospital, subject to availability. Second-opinion requests for leukemia, transplant eligibility and relapsed blood cancers are commonly supported.
Prof. Wu is associated with haematopoietic stem cell transplantation, CAR-T cell therapy, precision haematologic oncology, GVHD prevention and management, low-dose decitabine for post-transplant complications, and participation in phase 1/2 trials of investigational agents including a Menin-KMT2A inhibitor for relapsed acute leukaemia.
Connect with Depei Wu Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.